Based on the data presented in thisstudy, we propose three SMAD4-mediated processes that may contributeto CRC progression toward metastatic disease, although we cannot excludethe possibility that loss of SMAD4 influences other pro-metastaticprocesses as well. The gene discussed is SMAD4; the disease is metastatic neoplasm.